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Whatever the next hottest, scientifically
proven HIV treatment or prevention
strategies are, they will share a common
denominator for implementation: the HIV
test. Whether accessing preexposure pro-
phylaxis (PrEP), pursuing treatment as
prevention (‘‘test and treat’’), or taking
ART to improve individual clinical out-
comes, each begins with learning one’s
HIV status. With HIV testing as the
necessary gateway to so many interven-
tions, the paucity of people in resource-
limited settings who have ever had an HIV
test is astonishing. Despite over 100,000
facilities in low- and middle-income coun-
tries with HIV testing and counseling
capacity, only 34% of women and 17%
of men have ever had an HIV test in these
settings [1]. These facts call for novel and
far-reaching approaches to HIV screening,
and self-testing is one of them.
In this issue of PLoS Medicine, Augustine
Choko and colleagues are among the first to
describe the feasibility of an HIV self-testing
approach [2]. The paper demonstrated the
possible: randomly chosen participants in
high-density suburbs of Blantyre, Malawi
given modest direction could, and did,
accurately conduct oral HIV tests and
required minimal supervision. Only 8% of
subjects chose not to test, and self-testing
results were 99% concordant with rapid
finger-stick tests collected in parallel. Even
morepromising,nearlyhalfoftheparticipants
were men, a demographic population that has
been notoriously hard to engage in testing
initiatives in resource-limited settings [1,3].
Promise and Potential
Obstacles to Widespread Self-
testing Implementation
Despite Choko and colleagues’ encour-
aging results and the potential to reach an
untapped population, excitement about
implementation of self-testing must be
tempered. Over half of the population
sampled in this study report previous HIV
testing, and nearly a quarter had tested
within the past year. Demonstrating ac-
ceptability of self-testing in those with a
prior testing history is only the first step
towards ensuring that self-testing is gener-
ally feasible. Demonstrating its impact in
less-engaged populations, such as those
who refused or were never previously
offered testing, remains to be seen. Self-
testing has been available in the US for
over a decade; its use there—where clients
must be motivated enough to pay for it
themselves—has had minimal impact on
diminishing the large population of those
needing testing. Untested people have
generally lacked initiative and/or finances
to engage in self-testing, and 12% of those
identified as infected through self-testing
were those disbelieving and confirming a
prior positive test [4]. While the HIV
prevalence and economics differ vastly
between the US and Malawi, self-testing
will still require individual initiative yet to
be demonstrated beyond the study setting.
Through increased convenience, de-
creased stigma, and heightened privacy,that
self-testing might improve testing acceptabil-
ity seems obvious. Even so, the establish-
ment of any new testing mechanism gener-
ally faces unforeseen obstacles. In the case of
self-testing, these challenges may include:
demonstration of adequate participant buy-
in;availabilityofaneasy-to-useandaccurate
test that is durable to field conditions;
sufficient understanding by participants to
properly conduct the test and obtain the
correct result; and timely access to a health
care system equipped to answer questions,
assess for, and provide necessary treatment.
Shortfalls in any one of these areas may
r e s u l ti nat e s t i n gp r o g r a mt h a tn o to n l yf a i l s ,
but does harm. Look no further than the
2008 experience in Lesotho—a countrywith
a soaring HIV prevalence of 23% and in
dire need of increased stigma-free HIV case
identification—to see that a poorly con-
ceived and executed testing program can
backfire toward an infringement on human
rights and a campaign away from further
testing efforts [5].
Linkage to Care as a Measure of
Testing Success
One vital consideration as self-testing
traverses from the feasible to the implemented
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Linked Research Article
This Perspective discusses the
following new study published in
PLoS Medicine:
Choko AT, Desmond N, Webb EL,
Chavula K, Napierala-Mavedzenge S,
et al. (2011) The Uptake and Accu-
racy of Oral Kits for HIV Self-Testing
in High HIV Prevalence Setting: A
Cross-Sectional Feasibility Study in
Blantyre, Malawi. PLoS Med 8(10):
e1001102. doi:10.1371/journal.pmed.
1001102
Augustine Choko and colleagues
assess the uptake and acceptability
of home-based supervised oral HIV
self-testing in Malawi, demonstrat-
ing the feasibility of this approach
in a high-prevalence, low-income
environment.
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completion of a testing program—its
effective successful ‘‘endpoint’’ of diag-
nosing a previously unidentified case—is
not only documenting that the patient
received the appropriate result, but also
that the positive result ignited a cascade of
events leading to timely and effective
access to HIV-related care. Even in
highly successful clinic- or facility-based
HIV testing sites with accessible ART
programs, poor uptake of CD4 count
testing and subsequent assessment for
ART has been documented throughout
sub-Saharan Africa [6–8]. A systematic
review of retention in care between
testing and treatment in sub-Saharan
Africa estimates that less than 20% of
tested patients completed all the necessary
steps in the care cascade [9]. If self-testing
is preferred by people who feel healthy
and are motivated by privacy and an
unwillingness to acknowledge their HIV
status to others, those who self-test may be
even more likely to delay access to care
compared to people feeling ill undergoing
HIV testing in a health care facility. Even if
this is not the case, linkage to care for those
testing in locations outside the health care
system is likely to be a challenge. As self-
testing programs are designed and imple-
mented,theymustprovide convenient,free,
and easily accessible sites of referral—
accommodating those most in need of
proximity as well as those who strive for
the privacy that distance allows. Beyond
making care accessible, the next phase of
self-testing feasibility studies must evaluate
the completion of the care cascade from
testing to treatment to demonstratetrueself-
testing success.
Given severe limitations in prevention
and treatmentfunding,suchresourcesmust
be wisely invested. Cost-effectiveness stud-
ies reported that HIV screening in re-
source-limited settings represents a worthy
investment [10]. Such studies, however,
also demonstrated that for equal efficacy of
an intervention in the testing pathway,
investments are best targeted at later stages
in the testing and care cascade—and most
efficiently at interventions to promote
linkage to care [11,12]. That is, to ensure
investments are well-targeted in the scale
up of self-testing programs, linkage to care
is a critical evaluation measure. How to
conduct those linkage-to-care studies, while
maintaining the privacy that self-testing
demands, will be among the next phase of
self-testing implementation challenges.
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